XBP Global Holdings, Inc. 8-K

What Happened

• XBP Global Holdings, Inc. (XBP) filed an 8‑K on January 6, 2026, reporting that Nasdaq’s Listing Qualifications staff notified the company it has regained compliance with Nasdaq Listing Rule 5550(a)(2) (the $1 minimum bid price requirement).
• Nasdaq originally notified XBP of noncompliance on September 16, 2025; the company had a 180‑day cure period ending March 15, 2026. In a letter dated December 31, 2025, Nasdaq indicated the company had regained compliance and the matter is now closed.

Key Details

• Noncompliance notice received: September 16, 2025 (Nasdaq Listing Rule 5550(a)(2)).
• Cure period length: 180 calendar days (deadline March 15, 2026).
• Nasdaq confirmation of regained compliance: December 31, 2025.
• Filing date of 8‑K reporting the outcome: January 6, 2026 (signed by CFO Dejan Avramovic).

Why It Matters

• Regaining compliance means XBP avoided continued listing jeopardy related to the $1 minimum bid price rule, reducing the immediate risk of delisting and preserving Nasdaq listing benefits and market liquidity.
• This is a market‑structure/de-listing risk update rather than a financial performance disclosure; it does not change reported results but is material to holders because it affects the security’s continued listing status and tradability.